Amicus briefs fly in as IRA 'fair price' deadline looms
Amicus briefs are piling up in support of drug price negotiations under the Inflation Reduction Act ahead of a key February deadline by which the government is expected to propose fair prices for selected drugs.
AARP, advocacy groups like Public Citizen and Doctors for America, and researchers employed by leading universities have filed “friend of the court” briefs in support of drug price negotiations under the Inflation Reduction Act. Many of the arguments resemble points made in prior briefs defending the IRA, including ones filed in September in Merck’s case.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
